Lexicon Pharmaceuticals LXRX Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's treasury stock, shares (in shares)?
- Lexicon Pharmaceuticals (LXRX) reported treasury stock, shares (in shares) of $1.93M in Q1 2026.
- How has Lexicon Pharmaceuticals's treasury stock, shares (in shares) changed year-over-year?
- Lexicon Pharmaceuticals's treasury stock, shares (in shares) decreased by 18.8% year-over-year, from $2.38M to $1.93M.
- What is the long-term trend for Lexicon Pharmaceuticals's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), Lexicon Pharmaceuticals's treasury stock, shares (in shares) has grown at a 69.6% compound annual growth rate (CAGR), from $488.21K to $2.38M.